Bringing the fundamentals into focus…
Back to Charles River Laboratories International, Inc.
How Charles River Laboratories International, Inc. stacks up
CRL · against 120 other Healthcare companies of similar size
Growth
29/ 100
Near the bottom of its peers.
Ranked #106 of 121 · scores higher than 12% of peers
Bars: peers in each 10-point band of the growth score9 peers with a growth score of 20–29, including CRL · Click a bar to see the companies
Why growth scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 71% of peers. Revenue growth: -0.9% vs peer median 6.1%
- slower revenue growth over three years: weaker than 70% of peers. 3-year revenue growth: 0.3% vs peer median 5.8%
- Earnings per share growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = CRL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CRL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 122 reported | -0.9% | 9.9% | 8% | 33% | |
| Earnings per share growthHigher is better · 89 reported | Not reported | 18.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 117 reported | 0.3% | 10.7% | 11% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around CRL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 5 | 16.5B USD | 96 | 37 | |
| 101 | 1.13T INR (≈$13.5B) | 33 | 61 | |
| 101 | 12.3B USD | 33 | 35 | |
| 101 | 166.5B SEK (≈$16.6B) | 33 | 49 | |
| 105 | 10.8B USD | 31 | 35 | |
| 106 | 16.9B USD | 29 | 37 | |
| 106 | 18.2B USD | 29 | 40 | |
| 108 | 8.6B USD | 28 | 30 | |
| 108 | 154.4B BRL (≈$27.8B) | 28 | 43 | |
| 108 | 11.9B USD | 28 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score